Is MDB Capital Holdings, LLC Class A common (MDBH) a Buy, Sell, or Hold?
NASDAQ : MDBH
MDB Capital Holdings, LLC Class A common
$3.04 USD
$0.01 (0.33%)
- Volume
- 0
- Average Volume
- 4.33K
- Market Capitalization
- $30.68M
- P/E Ratio
- -1.43
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $4.80
- Year Low
- $2.45
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $36.63
Company Overview
NASDAQ
Christopher A. Marlett
Financial - Capital Markets
Financial Services
MDBH
14
US
USD
Liquidity Metrics
0.01
36.63
36.63
36.02
0.00
Sales & Valuation
$4.28M
5.86
0.55
-3.62
-0.83
Profitability
-$2.12
-$21.24M
-408.82%
-408.76%
-35.86%
-37.23%
P/E Metrics
-1.43
0.01
0.01
Analyst Price Target & Rating
3/5
0 Analysts
%
Financial Health Scores
13.42
4/9
$12.4M
$57.46M
$1.24M
-$18.94M
Key Metrics (TTM)
$18.62M
3.56
-0.98
36.63
-35.86%
-33.99%
-68.94%
-27.73%
1 days
Company Executives
| Name | Title |
|---|---|
| Anthony DiGiandomenico | Co-Founder, Head of New Venture Discovery & Director |
| Christopher A. Marlett | Co-Founder, Chief Executive Officer & Chairman |
| George H. Brandon | President, Head of Community Development & Director |
| Jeremy William James | Chief Financial Officer |
| Mohammad Hayat | Head of Corporate Development, Chief Legal Officer & Director |
| Tony Dammicci | Chief Experience Officer |
Poll Results
No votes yet today — be the first to share your view!
About MDB Capital Holdings, LLC Class A common (NASDAQ:MDBH) Stock
MDB Capital Holdings, LLC functions primarily as a broker-dealer through its subsidiary operations. The company's activities are divided into two main areas: Broker Dealer & Intellectual Property Service, and Technology Development. The Broker Dealer & Intellectual Property Service division provides comprehensive broker-dealer services, focusing on arranging private and public securities offerings, and furnishing research for investment banking due diligence. Meanwhile, the Technology Development division is engaged in the advancement of synthetic biology technology. MDB Capital Holdings, LLC was established in 1997 and is based in Addison, Texas. ...
2026-07-30 16:00:00
Addison, TX, July 30, 2026 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-defining, disruptive technology companies, will host a Zoom webinar on Thursday, August 13, 2026 at 4:30 p.m. Eastern Time to provide an operational update for the quarter ended June 30, 2026, and subsequent developments. A press release detailing the updates will be issued prior to the call.
What Is OpenAI Actually Patenting? PatentVest Pulse Analyzes OpenAI's Patent Portfolio
2026-07-23 12:45:00
New PatentVest Pulse report reveals how OpenAI's published patent portfolio maps its AI product strategy across conversational AI, AI agents, generative media, developer platforms, personalization, and infrastructure New PatentVest Pulse report reveals how OpenAI's published patent portfolio maps its AI product strategy across conversational AI, AI agents, generative media, developer platforms, personalization, and infrastructure
What Is OpenAI Actually Patenting? PatentVest Pulse Analyzes OpenAI's Patent Portfolio
2026-07-23 12:45:00
DALLAS, Texas, July 23, 2026 (GLOBE NEWSWIRE) -- PatentVest, the first fully integrated IP intelligence, strategy, and law firm, today released its latest PatentVest Pulse, an in-depth analysis of OpenAI's published patent portfolio and intellectual property strategy. Titled "What Is OpenAI Actually Patenting?
PatentVest Publishes New IP Legal Insights Article Examining Why Patent Prosecution Is Ready for AI
2026-07-02 11:05:00
Dallas, TX, July 02, 2026 (GLOBE NEWSWIRE) -- PatentVest today announced the publication of a new article in its IP Legal Insights section, continuing the firm's commitment to providing practical legal guidance on the technologies and legal developments reshaping intellectual property.
PatentVest Releases New PatentVest Pulse Report Exploring the Strategic Shift Beyond GLP-1
2026-06-30 09:30:00
The new PatentVest Pulse report examines how FGF21 is emerging as the next strategic cardiometabolic layer beyond GLP-1, reshaping obesity therapeutics, pharmaceutical partnerships, and intellectual property strategy The report analyzes more than $10. 7 billion in recent acquisitions and licensing activity, highlighting how leading pharmaceutical companies are positioning themselves for the next phase of obesity innovation Dallas, TX, June 30, 2026 (GLOBE NEWSWIRE) -- Today, PatentVest, a leading provider of IP Strategy and IP Law services, announced the release of its latest PatentVest Pulse report, "The Crossover: How FGF21 Became the Cardiometabolic Layer Beneath GLP-1.
PatentVest Releases New PatentVest Pulse Report Exploring the Strategic Shift Beyond GLP-1
2026-06-30 09:30:00
Dallas, TX, June 30, 2026 (GLOBE NEWSWIRE) -- Today, PatentVest, a leading provider of IP Strategy and IP Law services, announced the release of its latest PatentVest Pulse report, "The Crossover: How FGF21 Became the Cardiometabolic Layer Beneath GLP-1."
PatentVest to Present at Planet MicroCap Las Vegas on June 17
2026-06-15 12:30:00
PatentVest Will Discuss Intellectual Property Strategy, Innovation Intelligence, and the Future of AI-Native IP Services PatentVest Will Discuss Intellectual Property Strategy, Innovation Intelligence, and the Future of AI-Native IP Services
2026-06-04 13:05:00
• Analysis of 20 muscle-preservation programs highlights a rapidly emerging category designed to enhance long-term obesity treatment outcomes • PatentVest's report reveals how combination therapy IP, body-composition optimization, and strategic acquisitions may shape the next phase of obesity therapeutics Dallas, Texas, June 04, 2026 (GLOBE NEWSWIRE) -- Today, PatentVest, a leading provider of IP Strategy and IP Law services, announces the release of its latest report, "The Muscle Problem: How Myostatin Could Expand the GLP-1 Opportunity" This comprehensive study provides a strategic analysis of the emerging muscle-preservation category developing alongside obesity therapies.
Frequently Asked Questions
-
What is the current MDB Capital Holdings, LLC Class A common (MDBH) stock price?
-
MDB Capital Holdings, LLC Class A common(NASDAQ:MDBH) stock price is $3.04 in the last trading session. During the trading session, MDBH stock reached the peak price of $4.8 while $2.45 was the lowest point it dropped to. The percentage change in MDBH stock occurred in the recent session was 0.33% while the dollar amount for the price change in MDBH stock was $0.01.
-
MDBH's industry and sector of operation?
-
The NASDAQ listed MDBH is part of Financial - Capital Markets industry that operates in the broader Financial Services sector.
-
Who are the executives of MDBH?
-
Anthony DiGiandomenico | Co-Founder, Head of New Venture Discovery & Director
Christopher A. Marlett | Co-Founder, Chief Executive Officer & Chairman
George H. Brandon | President, Head of Community Development & Director
Jeremy William James | Chief Financial Officer
Mohammad Hayat | Head of Corporate Development, Chief Legal Officer & Director -
How many employees does MDBH have?
-
Number of MDBH employees currently stands at 14. MDBH operates from 14135 Midway Road, Addison, TX 75001, US.
-
Link for MDBH official website?
-
Official Website of MDBH is: https://www.mdb.com
-
How do I contact MDBH?
-
MDBH could be contacted at phone #(310) 526-5000 and can also be accessed through its website. MDBH operates from 14135 Midway Road, Addison, TX 75001, US.
-
How many shares of MDBH are traded daily?
-
The average number of MDBH shares traded daily for last 3 months was 4.33K.
-
What is the market cap of MDBH currently?
-
The market value of MDBH currently stands at $30.68M with its latest stock price at $3.04